logo
episode-header-image
Apr 2024
1h 2m

Extra: Why Is 23andMe Going Under? (Upda...

Freakonomics Radio + Stitcher
About this episode
Five years ago, we published an episode about the boom in home DNA testing kits, focusing on the high-flying firm 23andMe and its C.E.O. Anne Wojcicki. Their flight has been extremely bumpy since then. This update includes an additional interview with the Wall Street Journal reporter who has been investigating the firm’s collapse. 
Up next
Jul 31
683. In the New Space Race, Who Makes the Rules?
Governments started the space age. Now, billionaires and private firms are reinventing it. Guest host Steve Levitt explores what the past can teach us about a high-stakes future. (Part two of a two-part series.) SOURCES: Blaise Agüera y Arcas, vice president and fellow at Google, ... Show More
56m 27s
Jul 29
How Gary Gulman Turned Depression Into Comedy Gold | Better in Person
Gary and Stephen talk about creativity, recovery, getting fired, and holding grudges. They also get outside and play basketball, which is a big part of how Gary stays well. If you'd like to see the video version of Better in Person, watch it on YouTube or Apple Podcasts. Hosted b ... Show More
47m 6s
Jul 24
682. Should A.I. Move to Space?
At first it sounds ridiculous. But it might be inevitable. Guest host Steve Levitt talks to a team that hopes to push A.I. infrastructure off the planet. Part one of a two-part series.) SOURCES: Blaise Agüera y Arcas, vice president and fellow at Google, C.T.O. of technology and ... Show More
48m 18s
Recommended Episodes
Jun 2025
23andMe's Fatal Flaw | Defying Gravity? | 2
Plagued by low sales of its genetic tests, 23andMe adopts a bold new plan: slash prices and enter the pharmaceutical industry. But with investors nervous, can CEO Anne Wojcicki keep the show going long enough to make her DNA dream pay off?Be the first to know about Wondery’s newe ... Show More
39m 17s
May 2025
The drama and trauma of 23andMe
With the at-home DNA testing company 23andMe filing for bankruptcy, what happens to all the data millions of Americans handed over? And how should you approach the family you've found through sites like these? If you have a question, give us a call on 1-800-618-8545. Or send us a ... Show More
30m 45s
May 2025
The drama and trauma of 23andMe
With the at-home DNA testing company 23andMe filing for bankruptcy, what happens to all the data millions of Americans handed over? And how should you approach the family you've found through sites like these? If you have a question, give us a call on 1-800-618-8545. Or send us a ... Show More
30m 45s
Jun 2025
23andMe's Fatal Flaw | Great Expectorations | 1
When Silicon Valley power-player Anne Wojcicki sees gold in genetics, she forms 23andMe. She wants to bring genetic testing to the masses. But behind the hype and celebrity endorsements, can she build a company that’s selling more than just an expensive novelty product? Be the fi ... Show More
36m 42s
Mar 2025
The rise and fall of DNA testing company 23andMe
The genetic testing firm 23andMe has filed for bankruptcy, another twist in the story of a company that promised a pioneering approach to precision health. Now users are scrambling to delete their personal data, with the future ownership of the firm uncertain. To understand the h ... Show More
21m 49s
Aug 2024
How 23andMe went from a $6 billion valuation to trading for pennies
Cofounder and CEO of 23andMe, Anne Wojcicki, wants to take the public company private. Founded in 2006, the DNA-testing startup was valued at $6 billion in 2021. Now, it’s trading for less than a dollar. So what happened? ‘Fast Company’ senior writer Ainsley Harris breaks down 23 ... Show More
54m 45s
Apr 2025
How 23andMe's bankruptcy led to a run on the gene bank
Reporter Alexi Horowitz-Ghazi's Aunt Vovi signed up for 23andMe back in 2017, hoping to learn more about the genetic makeup of her ancestors. Vovi was one of over 15 million 23andMe customers who sent their saliva off to be analyzed by the company. But last month, 23andMe filed f ... Show More
30m 58s
Jun 2025
23andMe's Fatal Flaw | Guess Who’s Back | 3
Just when it looked like 23andMe was selling to Regeneron Pharmaceuticals, founder Anne Wojcicki placed a bid through her new nonprofit in an attempt to win it back at the eleventh hour. Lila MacLellan, Senior Writer at Fortune, joins David to discuss Wojcicki’s leadership style, ... Show More
37m 55s
Jan 2022
20VC: 23andMe's Anne Wojcicki on How To Approach Trust in Business and Personal Relationships, Leadership Lessons from Sheryl Sandberg and Reflections on How The Best Founders Manage Their Boards
tail spinning
41m 13s
Listen to millions of songs and podcasts on Anghami